Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
929
-
Total 13F shares, excl. options
-
356M
-
Shares change
-
+609K
-
Total reported value, excl. options
-
$27.7B
-
Value change
-
+$104M
-
Put/Call ratio
-
0.69
-
Number of buys
-
454
-
Number of sells
-
-437
-
Price
-
$77.77
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2024
1,116 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2024.
DEXCOM INC - Common Stock (DXCM) has 929 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 356M shares
of 392M outstanding shares and own 90.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (46.5M shares), BlackRock, Inc. (39.6M shares), STATE STREET CORP (16.7M shares), BAILLIE GIFFORD & CO (14.6M shares), Capital Research Global Investors (14.4M shares), SANDS CAPITAL MANAGEMENT, LLC (11.1M shares), GEODE CAPITAL MANAGEMENT, LLC (9.99M shares), Nuveen Asset Management, LLC (8.14M shares), JENNISON ASSOCIATES LLC (7.64M shares), and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (7.2M shares).
This table shows the top 929 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.